US$ 26.06
is retatrutide a glp 1 drug vs Semaglutide and Tirzepatide: GLP-3 Facts explained ๐ช๐ต๐ฎ๐ ๐ถ๐ ๐ฟ๐ฒ๐๐ฎ๐๐ฟ๐๐๐ถ๐ฑ๐ฒโ๐ฎ๐ป๐ฑ ๐๐ต๐ ๐ฎ๐ฟ๐ฒ
Description
The difference is that retatrutide adds glucagon receptor activity to GIP and GLP-1 activity, which is why the obesity research community is watching its long-term data closely
Endocrinology and Metabolism Clinics of North America

Semaglutide GLP-1 offers a unique approach by interacting with the brain and pancreas to suppress hunger and promote satiety

An actual system

In some patients, especially those with established retinopathy, a sharp metabolic improvement can briefly aggravate retinal findings before long-term benefit becomes clearer
